Target intelligence / Profile preview

Mycobacterium tuberculosis respiratory chain and cell membrane (Mtb respiratory chain/membrane)

Target
Mtb respiratory chain/membrane
Molecular classification
Enzyme, Transporter, Ion channel, Membrane protein
01

Overview

The Mycobacterium tuberculosis (Mtb) respiratory chain and cell membrane constitute a complex system of enzymes and structural components essential for the pathogen's survival, particularly during latent or persistent phases. The respiratory chain includes key complexes such as NADH dehydrogenase (NDH-1 and NDH-2), the cytochrome bc1-aa3 oxidase complex, and ATP synthase, which together generate the proton motive force required for ATP production (Cook et al., 2014). The mycobacterial membrane is uniquely characterized by a thick layer of mycolic acids, providing a robust physical barrier and anchoring various metabolic proteins (Kundu et al., 2017). This system is a major focus of modern antitubercular drug development; for instance, Bedaquiline inhibits the c-subunit of ATP synthase, while Telacebec targets the QcrB subunit of the cytochrome bcc complex (Andries et al., 2005; Pethe et al., 2013). By disrupting energy production and membrane stability, these drugs can effectively kill both actively replicating and non-replicating bacteria. However, because these processes are fundamental to life, therapeutic agents must be highly selective for mycobacterial proteins over human mitochondrial counterparts to minimize systemic toxicity (Bald et al., 2017).

Other names
Mtb oxidative phosphorylation systemMtb electron transport chainMycobacterial cell envelopeMtb bioenergetics pathway
02

Mechanism of action

Inhibition of ATP synthase, blockade of the cytochrome bcc complex, inhibition of NADH dehydrogenase, and disruption of mycolic acid synthesis or membrane potential.

03

Biological functions

Cellular respirationATP synthesisEnergy metabolismMembrane integrityHomeostasisProton motive force maintenance
04

Disease associations

Infection
05

Safety considerations

QT interval prolongationHepatotoxicityPotential mitochondrial toxicityDrug-drug interactions via CYP3A4
06

Interacting drugs

Bedaquiline

6 more in the full profile.

07

Biomarkers

Sputum culture conversionTime to positivity (TTP)Lipoarabinomannan (LAM) levelsMycolic acid profile

Beyond the preview

Go deeper on Mycobacterium tuberculosis respiratory chain and cell membrane (Mtb respiratory chain/membrane).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis respiratory chain and cell membrane (Mtb respiratory chain/membrane).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call